A statement from Diabetes Australia about the withdrawal of Fiasp from the PBS 1 March 2023 Diabetes Australia has been advised that Fiasp insulin will be removed from the Pharmaceutical Benefits Scheme from 1 April 2023. This means people will no longer be able to access it at a subsidised price. Fiasp will be available for people who choose to access it via private prescription; however, this will be more expensive. We understand this is causing distress for some people living with diabetes who currently use this medication. We have conveyed our concerns to Novo Nordisk and the Government, and are continuing these discussions to see what can be done to reduce the impact on people living with diabetes who are using this medication. In the meantime, if you are using Fiasp, we strongly encourage you to make an appointment with your doctor as soon as possible to discuss alternative insulins. If you have any questions or concerns, please contact Diabetes Australia on 1800 177 055.
Blog 8 May 2024 ‘No beauty shines brighter than a good heart’ Preventing heart disease is much easier than living with it. Please join our webinar to learn more about the links between diabetes and heart disease. Continue Reading
Blog 29 April 2024 Getting ready for the flu season: Vaccinate, please! Having the flu vaccine means you are less likely to become infected and, if you do become infected, you are more likely to only have a mild dose of the flu. Continue Reading
Blog 26 April 2024 Measuring your blood pressure at home Do you check your blood pressure regularly at home? If so, these 13 tips can help ensure you are getting the most accurate measurements. Continue Reading